Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, What steps he has taken to improve access to Liothyronine (T3) for the treatment of hypothyroidism?

No specific assessment has been made. NHS England’s guidance ‘Items which should not be routinely prescribed in primary care’ states that levothyroxine is the first treatment for hypothyroidism and liothyronine should not be routinely prescribed. However, the guidance states that liothyronine may be recommended for individual patients who may not respond to levothyroxine alone. NHS England is currently reviewing its guidance and has engaged with patient groups and other stakeholders to obtain feedback.